QSAR and Docking Studies of N-hydroxy Urea Derivatives as Flap Endonuclease-1 Inhibitors

dc.contributor.authorJadhav, Hemant R.
dc.date.accessioned2023-12-01T04:35:15Z
dc.date.available2023-12-01T04:35:15Z
dc.date.issued2015
dc.description.abstractFlap endonuclease-I (FEN-1) is involved in DNA repair and considered to be a novel target for the development of anticancer agents. N-hydroxy urea derivatives have been reported as FEN-1 inhibitors. To derive in vitro and in silico correlation, we have performed 2D-quantitative structure activity relationship (QSAR) analysis and docking studies on these compounds. 2D-QSAR models were developed using multiple linear regression (MLR) analysis and cross-validation using leave one out (LOO) method. The best model displayed R2 of 0.806 and Q2 of 0.607. Docking study revealed key interactions with desired amino acids and compare well with the in vitro potency of the reported compounds. Both studies reveal a link between FEN-1 inhibition and physicochemical descriptors or interactions with amino acids in active site. The information generated is first of its kind and may be helpful in the design of novel FEN-1 inhibitors.en_US
dc.identifier.urihttps://www.eurekaselect.com/article/72073
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13294
dc.language.isoenen_US
dc.publisherBentham Scienceen_US
dc.subjectPharmacyen_US
dc.subjectCanceren_US
dc.subjectQSARen_US
dc.subjectDockingen_US
dc.subjectFlap endonuclease-1en_US
dc.subjectGlideen_US
dc.subjectFEN-1en_US
dc.titleQSAR and Docking Studies of N-hydroxy Urea Derivatives as Flap Endonuclease-1 Inhibitorsen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: